Education
About Us
Working with TipRanks
Follow Us
CareRx (TSE:CRRX)
TSX:CRRX
CRRX Stock Chart & Stats
C$3.82
C$0.05(2.33%)
At close: 4:00 PM EST
C$3.82
C$0.05(2.33%)
Day’s Range― - ―
52-Week RangeC$2.36 - C$4.00
Previous CloseN/A
Volume3.32K
Average Volume (3M)71.09K
Market Cap
C$239.65M
Enterprise ValueC$307.06M
Total Cash (Recent Filing)C$16.02M
Total Debt (Recent Filing)C$81.96M
Price to Earnings (P/E)3820.0
Beta0.15
Next Earnings
Mar 11, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend Yield1.03%
Share Statistics
EPS (TTM)0.02
Shares Outstanding62,787,746
10 Day Avg. Volume18,484
30 Day Avg. Volume71,092
Financial Highlights & Ratios
PEG Ratio1.33
Price to Book (P/B)1.47
Price to Sales (P/S)0.34
P/FCF Ratio4.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$4.50Price Target Upside17.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring LTC Contract RevenueCareRx's core model is recurring, contract-driven pharmacy services for long-term care and retirement homes. This creates durable revenue visibility tied to resident populations and bed counts, supporting predictable dispensing volumes, stable cash flows and easier planning for service expansion or acquisitions.
Improving EBITDA And MarginsSustained margin expansion and rising adjusted EBITDA indicate operational leverage and better cost control across the dispensing and clinical services platform. Higher recurring operating profitability improves cash generation potential and strengthens capacity to reinvest in growth or fund dividends over the medium term.
Net Debt Reduction And Dividend InitiationReducing net debt to under 1x EBITDA while initiating a dividend signals improving balance-sheet flexibility and management confidence in cash flow durability. Lower leverage reduces financial risk and supports strategic optionality for acquisitions, reinvestment, or continued shareholder distribution over time.
Bears Say
Persistent Negative Net MarginsDespite EBITDA improvements, the company still reports negative net margins on a structural basis. That implies non-operational costs, interest or tax factors materially erode bottom-line returns, limiting retained earnings and constraining long-term equity accumulation and shareholder value creation.
Elevated Reliance On Debt FinancingA lower equity ratio and prior high leverage mean the business remains more sensitive to interest costs or tighter credit markets. Reliance on debt can limit strategic flexibility, raise refinancing risk, and amplify earnings volatility if cash flows weaken, making funding growth more costly over time.
Weaker Operating Cash Flow ConversionDeclining operating cash flow and a weakened conversion of earnings to cash point to working-capital volatility and operational timing effects. This reduces internal funding for capex, acquisitions or payouts, potentially forcing reliance on external financing and constraining durable investment in growth initiatives.
CareRx News
CRRX FAQ
What was CareRx’s price range in the past 12 months?
CareRx lowest stock price was C$2.36 and its highest was C$4.00 in the past 12 months.
What is CareRx’s market cap?
CareRx’s market cap is C$239.65M.
When is CareRx’s upcoming earnings report date?
CareRx’s upcoming earnings report date is Mar 11, 2026 which is in 17 days.
How were CareRx’s earnings last quarter?
CareRx released its earnings results on Nov 03, 2025. The company reported C$0.02 earnings per share for the quarter, missing the consensus estimate of C$0.026 by -C$0.006.
Is CareRx overvalued?
According to Wall Street analysts CareRx’s price is currently Undervalued.
Does CareRx pay dividends?
CareRx pays a Quarterly dividend of C$0.02 which represents an annual dividend yield of 1.03%. See more information on CareRx dividends here
What is CareRx’s EPS estimate?
CareRx’s EPS estimate is 0.02.
How many shares outstanding does CareRx have?
CareRx has 62,787,746 shares outstanding.
What happened to CareRx’s price movement after its last earnings report?
CareRx reported an EPS of C$0.02 in its last earnings report, missing expectations of C$0.026. Following the earnings report the stock price went up 4.309%.
Which hedge fund is a major shareholder of CareRx?
Currently, no hedge funds are holding shares in TSE:CRRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CareRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$4.50 (17.80% Upside)
C$4.50 (17.80% Upside)
Insider Transactions
Bought Shares
Worth C$21.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
71.66%
12-Months-Change
Fundamentals
Return on Equity
0.11%
Trailing 12-Months
Asset Growth
-0.13%
Trailing 12-Months
Company Description
CareRx
CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services. It serves approximately 50,000 residents in approximately 900 seniors and other communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.
CRRX Stock 12 Month Forecast
Average Price Target
C$4.50
▲(17.80% Upside)
Technical Analysis
Extendicare
―
Nova Leap Health
―
Sienna Senior Living
―
Medical Facilities
―
WELL Health Technologies Corp
―
Options Prices
Currently, No data available
---